BCDA — BioCardia Cashflow Statement
0.000.00%
Last trade - 00:00- $15.38m
- $14.40m
- $0.06m
Annual cashflow statement for BioCardia, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -15 | -12.6 | -11.9 | -11.6 | -7.95 |
| Depreciation | |||||
| Non-Cash Items | 2.94 | 2.26 | 1.48 | 1.36 | 1.07 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.365 | -0.063 | -0.214 | 0.152 | -1.22 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -12.4 | -10.4 | -10.6 | -9.97 | -8.03 |
| Capital Expenditures | -0.032 | -0.116 | -0.07 | -0.012 | -0.006 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.032 | -0.116 | -0.07 | -0.012 | -0.006 |
| Financing Cash Flow Items | -2.79 | -0.059 | -0.418 | -0.662 | -1.25 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 28.2 | 1.95 | 5.12 | 3.73 | 9.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 15.8 | -8.54 | -5.51 | -6.26 | 1.27 |